Hcn (Hyperpolarization Activated Cyclic Nucleotide Gated) Channel Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HCN Channel Neurons are neurons expressing HCN channels, which generate the hyperpolarization-activated current (Ih). These channels are critical for pacemaker activity, dendritic integration, and synaptic plasticity.
HCN channels expressed in:
- Thalamus: Relay neurons (Ih in thalamocortical neurons)
- Hippocampus: CA1 pyramidal neurons (dendritic Ih)
- Cortex: Layer 5 pyramidal neurons
- Striatum: Medium spiny neurons
- Locus coeruleus: Pacemaker neurons
- Substantia nigra: Dopaminergic neurons
- HCN1: Fast kinetics, cortex, hippocampus
- HCN2: Slow kinetics, thalamus, heart
- HCN3: Moderate kinetics, olfactory bulb
- HCN4: Very slow kinetics, thalamus, SA node
- Voltage dependence: Activated by hyperpolarization
- cAMP modulation: Direct binding accelerates activation
- Pore properties: Na⁺ and K⁺ permeability
- Pacemaker activity: Depolarizing sag
- Resting potential: Sets membrane potential
- Dendritic integration: Attenuates backpropagation
- Synaptic plasticity: Modulates LTP/LTD
- Theta rhythm: Thalamic and hippocampal oscillations
- HCN dysfunction in AD
- Aβ alters HCN function
- Cognitive deficits linked to Ih changes
- HCN changes in PD models
- Altered pacemaking in SNc neurons
- Therapeutic: HCN blockers (ivabradine)
- HCN downregulation in epilepsy
- Thalamic HCN in absence seizures
- Therapeutic potential
- HCN alterations in depression models
- Locus coeruleus HCN changes
- Antidepressant effects of HCN modulation
The study of Hcn (Hyperpolarization Activated Cyclic Nucleotide Gated) Channel Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ballesteros-Merino C, et al. (2012). HCN channel function and plasticity in learning. Physiological Reviews.
- Chan CS, et al. (2011). HCN channels and Parkinson's disease. Neuron.
- He C, et al. (2014). HCN in thalamocortical oscillations. Nature Neuroscience.
- Ludwig A, et al. (2003). HCN channels and cardiac pacemaking. Nature Reviews Neuroscience.
- Mormann F, et al. (2015). HCN and epilepsy. Brain.
- Nolan MF, et al. (2004). HCN1 and spatial memory. Cell.
- Santoro B, et al. (2011). HCN channel physiology. Handbook of Experimental Pharmacology.
- Surges R, et al. (2018). HCN as therapeutic target. Brain.
HCN channels are affected in Alzheimer's Disease and Parkinson's Disease, contributing to neuronal hyperexcitability.
- Hyperpolarization-activated cyclic nucleotide-gated channels
- Mixed cation permeability (Na+, K+)
- Voltage-dependent activation
- cAMP modulation
- Hippocampus (CA1, CA2)
- Thalamus
- Cortex
- Sensory neurons
- Resting membrane potential
- Synaptic integration
- Rhythm generation
- Dendritic integration
- Ivabradine: HCN4 blocker
- Reduces heart rate
- ZD7288: General HCN blocker
- Reduces seizure activity
- HCN channel blockers
- Analgesic potential
- DiFrancesco & DiFrancesco, HCN channels (2015)
- Biel et al., HCN pharmacology (2009)
- He et al., HCN and epilepsy (2014)